Before joining Sound Bioventures in September 2023, Fredrik was a venture partner at Industrifonden. Prior to this, he held senior executive and operational roles at several biotech companies, including Oncopeptides (head of research and CMC), Recipharm (General Manager) and EpiEndo (CEO and CMC). He has also founded several life science companies including OT Chemistry, which was acquired by Recipharm in 2015. Fredrik has a Ph.D. from Göteborg University and an executive MBA from Stockholm School of Economics. In addition, he has published over 50 peer reviewed articles and 25 patent applications.
Based in Stockholm, SE.
Read an interview with Fredrik Lehmann At the intersection of entrepreneurship, life science, & patient needs